{"name":"Bruker Corporation","slug":"bruker","ticker":"BRKR","exchange":"NASDAQ","domain":"bruker.com","description":"Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies (BEST) divisions.","hq":"Billerica, MA, USA","founded":0,"employees":"11085","ceo":"Frank H. Laukien","sector":"Scientific Instruments / Life Sciences Tools","stockPrice":38.05,"stockChange":1.38,"stockChangePercent":3.76,"marketCap":"$5.8B","metrics":{"revenue":3360000000,"revenueGrowth":-0.2,"grossMargin":48,"rdSpend":395200000,"netIncome":-8600000,"cash":298800000,"dividendYield":0.55,"peRatio":15.7,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Bruker Corporation Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Bruker Corporation reported its fourth quarter and full year 2023 financial results, with revenue of $1.23 billion and net income of $234 million.","drugName":"","sentiment":"positive"},{"date":"2023-09-07","type":"deal","headline":"Bruker Corporation Acquires Rigaku Corporation's X-ray Analytical Instrument Business","summary":"Bruker Corporation announced the acquisition of Rigaku Corporation's X-ray analytical instrument business, expanding its product offerings in the X-ray fluorescence (XRF) and X-ray diffraction (XRD) markets.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-04-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNVW1BQlk1NVRVRWV0LWM3TlpzTjdtX2hQbDVyaGFiRy1qSnB1TTlZUExOYXREbjFmTEJ5TnFfTnZLV3NQZVZLQUEwYlVaa3JLYng4TTZlbW9hcXVOMmNDNUZQaXRlN3ZFU2tMRENuYjhELTRlZnZ3V1BuUWRwZl9uZl82clpzakFmLWpxNlJLZ2NoMkRDOG9rMjBScjFGVTFIN2Jidnc4cFRfdjBLTENLZlY3dlkyMjJzUVdlNUlDcw?oc=5","date":"2026-03-15","type":"pipeline","source":"AD HOC NEWS","summary":"Bruker Corp Stock (ISIN: US1167941087) Faces Rising Short Interest Amid Investor Scrutiny - AD HOC NEWS","headline":"Bruker Corp Stock (ISIN: US1167941087) Faces Rising Short Interest Amid Investor Scrutiny","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQV2lkUTVlRHdMUVNSZ0RIRzFmNkRmX2JxMU1xWDU3ellZeVJRaEFscEltMWtaVm5XdDVEdkFtUGYyMEhHamRSaE1kQnk1UF91NktLbWhpMzYzdUE1Y01UMGFlNkJjcm51TnV6WGl2VXdpWElkWHhMUmhjeDA2SEQ5ZDJSTTE3QjZjb1RRLUphbmhZU1I5R0Z6ZUljRk5mRUd1S0hJWHAxNDI?oc=5","date":"2026-03-04","type":"earnings","source":"Finviz","summary":"Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers - Finviz","headline":"Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers","sentiment":"neutral"},{"date":"2026-02-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-15","type":"pipeline","source":"simplywall.st","summary":"Analysts Have Been Trimming Their Bruker Corporation (NASDAQ:BRKR) Price Target After Its Latest Report - simplywall.st","headline":"Analysts Have Been Trimming Their Bruker Corporation (NASDAQ:BRKR) Price Target After Its Latest Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPVG02b3hweHAzZkZlcl9GRzFDcGI5U1dpUENjdVc3RmpmbWdHa1kyT2hLblNxTk1XcnpkNHJYMEJ5eG5iN2lIZDZzZW1nMXk1OHVWVl9HdGNCUmtlQmJKRG1MNjAxbnZxVHBkWlVrOVlxd0ZRUkFGanNUUERrVTNsZTlsQk5BTmhIZ0pHS3hJYzAzMDhJcUZLYlVzMDYxOGUxX1o1cmdTNDAzRDd3SmhjZzZUbjYwSF9sUzJNOVNialc2ZlQtZ25HbUNPSVFWNFNaaW9ONFVKNNIB3AFBVV95cUxObUNrLXkyNzBFNFlCTVBNWVAwdkszZzNPMXcyN0Q1dXg3TFZSeVlCMnJfZWR1NzBzUjYtd1h3b0hJZ25pWG9BMkFKbFliMkRnMzFiRGE2VExJYlRqN3RBX0hCSHFaR3lOZVV2WllQZ1Y0dTVad2RlMUk0WUJoVW55d1hKbm1fQURZT1MwbDk0MF9iRFhQQVR3TE9ETFpQcUFVTEdmd3dIci03dHFiZlFaWjAwU1piamgyU3Z0TUNnYVBQaGlScGFDdjk4c1RQQmxDRDdNTzZrSE5wZy1X?oc=5","date":"2026-02-13","type":"earnings","source":"simplywall.st","summary":"Bruker (BRKR) Q3 Loss Of US$62 Million Tests Bullish Margin Narratives - simplywall.st","headline":"Bruker (BRKR) Q3 Loss Of US$62 Million Tests Bullish Margin Narratives","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-13","type":"earnings","source":"AlphaStreet","summary":"Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook - AlphaStreet","headline":"Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOSnJpTUVlUVg2RFBnbzBrUVF6RjMwa3NRencxV2J1YTIwR1BjQnV3ME12VWlzNW9jM3JlM0E0ejFNNmE4NmhhTDVMZll4NkJXb2MwOUtHdU0ycF9fOU5Nck14bUdHamh1dnVVT2VDNDh3cDhlWGhJbzJJUUFkY0VHRVloTjNVZ2RTbWgwZHVLX2E3aW04cUxmMi1uM1lKdW96c3c2NzhEY2ZoT2M4ZWFsLXByY2JTTm5oT1E2MDRVQXRxQzdDYTlBbFJiSW4tYmhqdGYtcFVNQlVfZ2JuNmdrYUkwT2VHT0RVVktucFRDbk9nQnFLRFVueFdtRElpd3RQNDBtVWJ5b3pOQ3gwOC1PZFl4TzVyMDk2?oc=5","date":"2026-02-09","type":"regulatory","source":"Business Wire","summary":"Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC - Business Wire","headline":"Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Dev","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPSFRjU0k2V2l6WFI5YnNvYXB3RU9ZWFVFaUdFOG5FZU1HZ3dESEJ2SXFnR2RHLXhQOURMNFdVNS1QUWVxUHgzR3o2TTFkR2puQ1hROUs0d2drMjVrZ05aOXpKUFE2dk9Sa2FmUUYySm1GWEk5d0MtT1l5c2FjY0RoTG5lWE5pMy1Z?oc=5","date":"2025-12-12","type":"pipeline","source":"Yahoo Finance","summary":"Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR) - Yahoo Finance","headline":"Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQOVdtTnFxRmJ0WUpEcmpMT2NGX29wYkRXdFY1TkRFdU5sYzdCUk44VkJkd2J4bzA3VGFOWk9haXZ1ZzNkckx0NU9BcEpfanZHd1hXVmxnS1B3NzVLQlhYaVJYbzVLbkZvN3NwWXNtaFY1UXI4SUV5VXRMdkFnaGNBdFZBVXRPYjRpTkZRN0xYNTNhWERwdXE2Y05BZ093M2xzejR5RUd2ekpzUGpHd2RXcHNxVVdFbmlVQ19ReEpXTmcyMGFMY0N3YWl0THg2OHU4a2hYeUFhMNIB3AFBVV95cUxNYWp4cEhxVm0xY3lJSmZGblFuNkN2eW1ENnRMVDNHd2VmLWp5aVBtRzhoSUZQbVZXWmhvRmd3N2FDN2ExSEJ1NWozSkxvY1Y5ZGhjVFVkTnRLYW9nTzNuSG1hWGlYSE5kVjdBSGh3SDVDM2kwSW1wV2xrcHFtNncwLTAza2k5SjgyaWk1UzY2TWdqRkVJaDlnaGVha2JfbzFzcHNINDlYR3ktYkN2aGd3MUNMRy1yZFFrbkZjbmRNRzVMQW5oNkozUG1fQTJ4S2MwaFlqckJ3RllHZlNU?oc=5","date":"2025-11-26","type":"pipeline","source":"simplywall.st","summary":"Bruker Corporation's (NASDAQ:BRKR) Shares Bounce 26% But Its Business Still Trails The Industry - simplywall.st","headline":"Bruker Corporation's (NASDAQ:BRKR) Shares Bounce 26% But Its Business Still Trails The Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOVUVaVEx0R0NfMHpSOGppOUNoT0xhYWxzVE5zWmVDXzd1dUl4VXFuemFmbGJzVnJBOGRPUnNSQzFEeGZMWW9Vel9vRHJTOGZlQ0cxVVh1WE1CRmw1aUlYWWM0b1BKOUloZHd3Z1Vxc1JFOEJQOHJ3LVA4Nl94WXFucERvbDBnUVJ0clpxTGhzcGxuakRkMW9hTnVwUVktQzg5b0pGQ283RzRzb1VkU2c4?oc=5","date":"2025-09-23","type":"earnings","source":"International Business Times UK","summary":"The Big Short's Michael Burry Splurges $42M in 5 New Stocks in Q2, Leading With Apparel and Pharma - International Business Times UK","headline":"The Big Short's Michael Burry Splurges $42M in 5 New Stocks in Q2, Leading With Apparel and Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOeENqUzFIdWotOVEwc25QWkR2eFV2eUpoeGxJZlZWQ0Q3NW1acnhycVZKemw4aG84bW1sZjhMb2tXa2tOUkIxQm42VGhhTW1CR001ckZKWEYzc3Vka0k2cGFubEVIeUlvLVNuNlNGRHBSTWh2WVhhaS0ySFBDVVhzaDJQcWN0X2ZCRnBz?oc=5","date":"2025-08-22","type":"deal","source":"TIKR.com","summary":"Michael Burry’s 6 Most Contrarian Bets & Recent Buys in 2025 - TIKR.com","headline":"Michael Burry’s 6 Most Contrarian Bets & Recent Buys in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPRURGbm8xLVpwb2xGdXFsSWdab1Vab1lmTnA0c21NbFNUTUtDU0NGT2piaWttTndWRVVKN0syd213RG9fVmJiQ3VzYzRHcTMxdDI3Q2NhV2pYNzI4X0tJQ2tIRnV0VTZNZS15VXR6dEthcldySU5uNTVNRlJ1RWEwY2wyVzlENFJMR1o2ZHdHbUJzS2NVYmxuWXRNdm5fdXR0enhwUERxM0dYZFROSm1IY085NW9FZmhtMGQ5SXF1alY0ckVTMTZxQXNiNVBqNnQxeVZHU2JSM09Xb3VoV0lmR3Y5U3RDanRmUnAxZ3o3YU5lYVl0MVEtT01pMTA3NWtBUHVYaTZB?oc=5","date":"2025-08-13","type":"deal","source":"TradingView","summary":"Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - TradingView","headline":"Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNMUZCMU0zTDEtT194dGo5RVdDOTY2TDRPT1dCbXJRZWFxbTJZemxyTWV6d1pyNTlTZHVDTjM3WTJfZFlwTDRBMUhjZzdjekV5dmJCT3RiTTlqd2hpQ3d2MWZDMmVSdm5vb29XZUI4VFpUbWQ5NnZPTzYtbjVpUjc2V2pfWDFpQmswMU43VjlWVU1fbUplTU5nRXRDMjA0QnBIMXlpek5ocmdDc1pROTZCR1BIVWFoMnU3Z3FWZW83eFRSNC12WTNuNEM4dw?oc=5","date":"2025-01-08","type":"pipeline","source":"GuruFocus","summary":"Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research - GuruFocus","headline":"Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Agilent Technologies","Thermo Fisher Scientific","PerkinElmer"],"therapeuticFocus":["Materials Science","Pharmaceuticals","Biotechnology"],"financials":{"source":"sec_edgar","revenue":1895600000,"revenuePeriod":"2018-12-31","revenueHistory":[{"value":1895600000,"period":"2018-12-31"},{"value":466600000,"period":"2018-09-30"},{"value":443700000,"period":"2018-06-30"},{"value":431700000,"period":"2018-03-31"},{"value":1765900000,"period":"2017-12-31"},{"value":435600000,"period":"2017-09-30"}],"grossProfit":1577700000,"grossProfitHistory":[],"rdSpend":395200000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-8600000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":298800000,"cashHistory":[],"totalAssets":6241400000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":38.05,"previousClose":36.67,"fiftyTwoWeekHigh":56.22,"fiftyTwoWeekLow":28.53,"fiftyTwoWeekRange":"28.53 - 56.22","fiftyDayAverage":38.88,"twoHundredDayAverage":39.84,"beta":1.2,"enterpriseValue":7379780096,"forwardPE":15.7,"priceToBook":2.36,"priceToSales":1.69,"enterpriseToRevenue":2.15,"enterpriseToEbitda":14.76,"pegRatio":0,"ebitda":499900000,"ebitdaMargin":14.5,"freeCashflow":216962496,"operatingCashflow":134100000,"totalDebt":2042899968,"debtToEquity":81.4,"currentRatio":1.73,"returnOnAssets":2.9,"returnOnEquity":-0.4,"analystRating":"2.1 - Buy","recommendationKey":"buy","numberOfAnalysts":14,"targetMeanPrice":47.86,"targetHighPrice":70,"targetLowPrice":35,"dividendRate":0.2,"payoutRatio":0.38,"fiveYearAvgDividendYield":0.33,"exDividendDate":1774224000,"insiderHeldPercent":31.9,"institutionHeldPercent":92.4,"sharesOutstanding":152219250,"floatShares":103580633,"sharesShort":10660402,"shortRatio":5.01,"shortPercentOfFloat":7,"epsTrailing":-0.15,"epsForward":2.42,"revenuePerShare":22.64,"bookValue":16.15,"officers":[{"age":65,"name":"Dr. Frank H. Laukien Ph.D.","title":"Chairman, CEO & President"},{"age":63,"name":"Dr. Mark R. Munch Ph.D.","title":"Corporate Executive VP and President of Bruker Nano Group & Corporate"},{"age":70,"name":"Mr. Juergen  Srega","title":"President of Bruker CALID Group & Bruker Daltonics Division"},{"age":57,"name":"Dr. Falko  Busse Ph.D.","title":"President of Bruker BioSpin Group"},{"age":50,"name":"Mr. Thomas M. Bures","title":"Chief Accounting Officer"},{"age":50,"name":"Mr. J. Brent Alldredge J.D.","title":"Senior VP, General Counsel, Secretary & Global Head of Compliance"},{"age":58,"name":"Dr. Burkhard  Prause Ph.D.","title":"President and CEO of Bruker Energy & Supercon Technologies, Inc."}],"industry":"Medical Devices","irWebsite":"http://ir.bruker.com/phoenix.zhtml?c=121496&p=irol-IRHome","website":"https://www.bruker.com","phone":"978 663 3660"}}